06.12.2023 13:55:16
|
AstroNova Q3 Net Income Rises
(RTTNews) - AstroNova, Inc. (ALOT) reported third quarter net income of $2.8 million, or $0.37 per share, compared with $289 thousand, or $0.04 per share, a year ago. On a non-GAAP basis, net income for the third quarter of fiscal 2023 was $829 thousand, or $0.11 per share.
Third quarter total revenue was $37.5 million, down 4.7% from the year-earlier period. The company said the decrease reflected lower revenue in the PI segment, due primarily to lower supplies revenue from printers impacted by the defective ink from one of larger suppliers and, in part, to the company's product rationalization initiatives. Hardware revenue was $12.9 million, a 7.7% increase.
Bookings for the third quarter increased 1% to $35.5 million from $35.0 million in the third quarter of prior year. Backlog as of October 28, 2023 decreased 20% to $31.2 million from $39.3 million as of October 29, 2022.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Astro-Med Inc.mehr Nachrichten
19.12.24 |
NASDAQ Composite Index-Titel Astro-Med-Aktie: So viel Verlust hätte ein Astro-Med-Investment von vor einem Jahr eingefahren (finanzen.at) | |
18.12.24 |
Schwache Performance in New York: NASDAQ Composite fällt zum Handelsstart (finanzen.at) | |
13.12.24 |
Optimismus in New York: NASDAQ Composite letztendlich mit Zuschlägen (finanzen.at) | |
13.12.24 |
NASDAQ-Handel: NASDAQ Composite zum Start des Freitagshandels in der Gewinnzone (finanzen.at) | |
12.12.24 |
Angespannte Stimmung in New York: NASDAQ Composite schwächelt (finanzen.at) | |
12.12.24 |
Schwacher Wochentag in New York: NASDAQ Composite leichter (finanzen.at) | |
12.12.24 |
Schwacher Handel in New York: NASDAQ Composite verbucht zum Start Abschläge (finanzen.at) | |
12.12.24 |
NASDAQ Composite Index-Wert Astro-Med-Aktie: So viel Gewinn hätte ein Investment in Astro-Med von vor 10 Jahren eingebracht (finanzen.at) |